Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
Helius Medical Technologies, Inc. - Class A (HSDT)
NASDAQ:AMEX Investor Relations:
heliusmedical.com/index.php/investor-relations/overview
Company Research
Source: GlobeNewswire
NEWTOWN, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the first quarter ended March 31, 2019. First Quarter 2019 Financial Summary Revenue of $0.7 million, compared to no revenue in first quarter 2018.Operating loss of $6.8 million, compared to operating loss of $4.7 million in first quarter 2018.Net income of $1.3 million, compared to net loss of $1.2 million in first quarter 2018. First Quarter and Recent Business Highlights On March 5, 2019, the Company announced the first patients in Canada have begun PoNS Treatment.On April 10, 2019, the Company announced that the U.S. Food and Drug Administration (the “FDA”) had completed its review of the Company’s request for de novo classification and 510(k) clearance of the Portable Neuromodulation Stimulator (PoNS) device and declined the Company’s request.
Show less
Read more
Impact Snapshot
Event Time:
HSDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSDT alerts
High impacting Helius Medical Technologies, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
HSDT
News
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center [Yahoo! Finance]Yahoo! Finance
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterGlobeNewswire
- FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers [Seeking Alpha]Seeking Alpha
- Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ [Yahoo! Finance]Yahoo! Finance
HSDT
Earnings
- 3/28/24 - Beat
HSDT
Sec Filings
- 4/26/24 - Form S-1/A
- 4/15/24 - Form S-1
- 4/5/24 - Form 8-K
- HSDT's page on the SEC website